Price (delayed)
$2.47
Market cap
$76.79M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.9
Enterprise value
$80.44M
DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform
There are no recent dividends present for DMTK.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.